Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Toddaculine may be beneficial for the prevention and treatment of osteoporosis, it can not only inhibit the differentiation of osteoclasts via activation of the NF-κB, ERK 1/2, and p38 MAPK signaling pathways, but can induce differentiation and mineralization of osteoblasts by regulating differentiation factors. Toddaculine also may serve as a pharmacological prototype for the development of novel anti-leukemic agents, it displays a dual effect as a cell differentiating agent and apoptosis inducer in U-937 cells.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 35,500 | |||
5 mg | 在庫あり | ¥ 89,500 | |||
10 mg | 在庫あり | ¥ 130,500 | |||
25 mg | 在庫あり | ¥ 202,500 | |||
50 mg | 在庫あり | ¥ 273,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 80,000 |
説明 | Toddaculine may be beneficial for the prevention and treatment of osteoporosis, it can not only inhibit the differentiation of osteoclasts via activation of the NF-κB, ERK 1/2, and p38 MAPK signaling pathways, but can induce differentiation and mineralization of osteoblasts by regulating differentiation factors. Toddaculine also may serve as a pharmacological prototype for the development of novel anti-leukemic agents, it displays a dual effect as a cell differentiating agent and apoptosis inducer in U-937 cells. |
In vitro | toddaculin displays a dual effect as a cell differentiating agent and apoptosis inducer in U-937 cells, suggesting it may serve as a pharmacological prototype for the development of novel anti-leukemic agents[1]. |
植物由来 |
分子量 | 274.31 |
分子式 | C16H18O4 |
CAS No. | 4335-12-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/ml (200.51 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Toddaculin 4335-12-0 Others inhibit osteoclast Inhibitor differentiation leukemic Apoptosis osteoblast anti-inflammatory coumarin inhibitor